• Dr Jelle Thole
    Dr Jelle TholeDirector Product and Clinical Development TBVI
    • Dr Brijesh Patel (chair)
      Dr Brijesh Patel (chair)Former Deputy Manager and Senior Assessor Biologicals and Biotechnology Unit, MHRA (Medicines and Healthcare products Regulatory Agency) London, United Kingdom
      • Dr Bernard Fritzell
        Dr Bernard FritzellFormer Vice-President, International Scientific & Clinical Affairs, Pfizer Vaccines Research Former Chairman of the clinical working group of the European Vaccines Manufacturers (EVM) Paris, France
        • Dr Emmanuèle Gerdil
          Dr Emmanuèle GerdilFormer Executive Director, Regulatory Affairs Europe at Sanofi Pasteur MSD Lyon, France
          • Dr Mei Mei Ho
            Dr Mei Mei HoPrincipal Scientist National Institute for Biological Standards and Control Hertfordshire, United Kingdom
            • Beatrice De Vos, MD, PhD, BCPM
              Beatrice De Vos, MD, PhD, BCPMPresident of the board of directors of ASIT biotech
              • Dr Leo van der Pol
                Dr Leo van der PolPrincipal scientist Intravacc Bilthoven, The Netherlands
                • Dr François Spertini
                  Dr François Spertini Dr François Spertini Associate Professor of Medicine, University of Lausanne Chief-physician, Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland
                  • Dr Georges Thiry PhD
                    Dr Georges Thiry PhDFormer Deputy Director-General, Portfolio Management at IVI and acting Director for the Dengue Vaccine Initiative (DVI).
                    • Dr Eddy Rommel
                      Dr Eddy RommelManaging Director Rommel Consulting Partners Jodoigne, Belgium